Mesoblast (MESO) - 2023 Q2 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________ Form 6-K ________________________________________ Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 Filed in the month of February 2023 for the period ended December 31, 2022 Commission File Number 001-37626 ________________________________________ Mesoblast Limited (Exact name of Registrant as specified in its charter) ...